Photodynamic TherapyPhotodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

Sponsor:

SpectraCure AB

Code:

NCT06807359

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Photodynamic Therapy (PDT)

Verteporfin Injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-24. This information was provided to ClinicalTrials.gov by SpectraCure AB on 2026-05-01.